CAR T-cells are a particularly exciting therapeutic area, which was widely covered at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA. In this video, Graham Collins, MRCP, FRCPath, DPhil, of Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses his highlights of the CAR T-cell data presented at the meeting in regards to lymphoma. Dr Collins covers the promising longer-term results being seen now in overall and complete response rates, the main caveat to the data and the questions that we can expect to be answered by further studies.
CAR T-cells for lymphoma: data from ASH 2017
